Download PDF
Fortschr Neurol Psychiatr 2008; 76(12): 715-724
DOI: 10.1055/s-2008-1038293
Übersicht
© Georg Thieme Verlag KG Stuttgart · New York

Depression beim idiopathischen Parkinson-Syndrom

Teil 1: Epidemiologie, Pathophysiologie, Klinik und DiagnostikDepression in Parkinson's DiseasePart 1: Epidemiology, Signs and Symptoms, Pathophysiology and DiagnosisA.  Storch1 , G.  Ebersbach2 , G.  Fuchs3 , W.  H.  Jost4 , P.  Odin5 , G.  Reifschneider6 , M.  Bauer7
  • 1Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus, Dresden
  • 2Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson, Beelitz-Heilstätten
  • 3Neurologisches Krankenhaus, Parkinson-Fachklinik, Wolfach
  • 4Deutsche Klinik für Diagnostik (DKD), Wiesbaden
  • 5Neurologische Klinik, Klinikum Bremerhaven Reinkenheide, Bremerhaven
  • 6Neuro Centrum Odenwald, Erbach
  • 7Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Dresden
Further Information

Publication History

Publication Date:
14 November 2008 (online)

    Permissions and Reprints

Zusammenfassung

Nicht-motorische Störungen des idiopathischen Parkinson-Syndroms (IPS) wie depressive Symptome finden in den letzten Jahren zunehmend Beachtung, da sie die Lebensqualität der Patienten maßgeblich beeinträchtigen und sich auch auf die motorische Behinderung negativ auswirken. In der Gruppe der neuropsychiatrischen Störungen sind die depressiven Symptome am häufigsten. Doch trotz Häufigkeit und zunehmender Bedeutung wird die Depression beim IPS häufig nicht erkannt. Diagnostische Probleme bereiten die Symptomüberlappung depressiver Symptome mit motorischen und kognitiven Symptomen des IPS. Zudem fehlt es an validierten und standardisierten Meßmethoden, was letztlich auch dazu geführt hat, dass bislang keine genauen Angaben zur Frequenz depressiver Symptome bei Parkinsonerkrankungen vorliegen. Entsprechend finden sich in der Literatur je nach verwendetem Diagnoseinstrumentarium und Studiendesign Angaben zur Prävalenz depressiver Symptome beim IPS, die von 7 – 72 % reichen, mit ca. 40 % in den meisten Querschnittsstudien. Während es zu Prävalenz und Psychopathologie depressiver Störungen einige Studien mit unselektierten Parkinson-Patienten gibt, ist nur wenig über deren Genese und Langzeitverlauf bekannt. Die vorliegende Arbeit fasst die zurzeit vorliegenden Erkenntnisse zu Bedeutung, Häufigkeit, Pathogenese und Diagnostik depressiver Symptome beim IPS zusammen und schlägt auf der Basis vorhandener Daten ein Prozedere zu Screening und Diagnostik vor.

Abstract

Non-motor symptoms, such as psychiatric symptoms and autonomic dysfunction, are common co-morbid conditions in Parkinson's disease (PD) and major contributors to poor quality of life and disability. Within the group of neuropsychiatric conditions, depressive symptoms are the most common condition. Despite their frequency and importance, depressive symptoms can be difficult to assess and diagnose and thus depression in PD is frequently unrealized. Diagnostic challenges include the overlap of depressive symptoms with motor and non-motor symptoms of PD, such as dementia and apathy. Furthermore, there are no definite standards to assess and diagnose depression in PD leading also to the lack of exact data on the epidemiology of this non-motor symptom in PD. Depending on the diagnostic test and the study design the prevalence of depression in PD is reported between 7 and 72 % of PD patients with approximately 40 % in most cross-sectional studies. In contrast, the pathogenesis and long-term course of depression in PD remain elusive. Current hypothesis, however, includes that depressive symptoms are part of the core condition of PD when regarded as an entity. The present review summarizes the current knowledge on epidemiology, pathogenesis and diagnosis of depression in PD and proposes on this data base a standard procedure for screening and diagnosis of depressive symptoms in PD.

Schlüsselwörter

Depression - Morbus Parkinson - Epidemiologie - Pathophysiologie - Diagnostik - Skalen

Key words

depression - Parkinson's disease - epidemiology - pathophysiology - diagnosis - scales

Literatur

  • 1 Schrag A. Quality of life and depression in Parkinson's disease.  Journal of the neurological sciences. 2006;  248 151-157
    Google Scholar
  • 2 Weintraub D, Moberg P J, Duda J E. et al . Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.  Journal of the American Geriatrics Society. 2004;  52 784-788
    Google Scholar
  • 3 Shulman L M, Taback R L, Rabinstein A A. et al . Non-recognition of depression and other non-motor symptoms in Parkinson's disease.  Parkinsonism Relat Disord. 2002;  8 193-197
    Google Scholar
  • 4 Weintraub D, Moberg P J, Duda J E. et al . Recognition and treatment of depression in Parkinson's disease.  Journal of geriatric psychiatry and neurology. 2003;  16 178-183
    Google Scholar
  • 5 Chaudhuri K R, Healy D G, Schapira A H. Non-motor symptoms of Parkinson's disease: diagnosis and management.  Lancet neurology. 2006;  5 235-245
    Google Scholar
  • 6 Veazey C, Aki S O, Cook K F. et al . Prevalence and treatment of depression in Parkinson's disease.  The Journal of neuropsychiatry and clinical neurosciences. 2005;  17 310-323
    Google Scholar
  • 7 Taylor A E, Saint-Cyr J A, Lang A E. et al . Parkinson's disease and depression. A critical re-evaluation.  Brain. 1986;  109 ( Pt 2) 279-292
    Google Scholar
  • 8 Nilsson F M, Kessing L V, Sorensen T M. et al . Major depressive disorder in Parkinson's disease: a register-based study.  Acta psychiatrica Scandinavica. 2002;  106 202-211
    Google Scholar
  • 9 Mayeux R, Stern Y, Rosen J. et al . Depression, intellectual impairment, and Parkinson disease.  Neurology. 1981;  31 645-650
    Google Scholar
  • 10 Ehmann T S, Beninger R J, Gawel M J. et al . Depressive symptoms in Parkinson's disease: a comparison with disabled control subjects.  Journal of geriatric psychiatry and neurology. 1990;  3 3-9
    Google Scholar
  • 11 Slaughter J R, Slaughter K A, Nichols D. et al . Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease.  The Journal of neuropsychiatry and clinical neurosciences. 2001;  13 187-196
    Google Scholar
  • 12 McDonald W M, Richard I H, DeLong M R. Prevalence, etiology, and treatment of depression in Parkinson's disease.  Biological psychiatry. 2003;  54 363-375
    Google Scholar
  • 13 Leentjens A F. Depression in Parkinson's disease: conceptual issues and clinical challenges.  Journal of geriatric psychiatry and neurology. 2004;  17 120-126
    Google Scholar
  • 14 Hughes A J, Daniel S E, Blankson S. et al . A clinicopathologic study of 100 cases of Parkinson's disease.  Arch Neurol. 1993;  50 140-148
    Google Scholar
  • 15 Hughes A J, Daniel S E, Kilford L. et al . Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.  J Neurol Neurosurg Psychiatry. 1992;  55 181-184
    Google Scholar
  • 16 Yesavage J A, Brink T L, Rose T L. et al . Development and validation of a geriatric depression screening scale: a preliminary report.  Journal of psychiatric research. 1982;  17 37-49
    Google Scholar
  • 17 Ravina B, Camicioli R, Como P G. et al . The impact of depressive symptoms in early Parkinson disease.  Neurology. 2007;  69 342-347
    Google Scholar
  • 18 Barone P, Groot A A, Goetz C G. et al .Depression and antidepression use in Parkinson's disease: results from the PRODEST-PD study. Brussels: 11th Congress of the European Federation of Neurological Societies (EFNS) 25 – 28 Aug 2007
    Google Scholar
  • 19 Pedersen K F, Larsen J P, Alves G. et al . Prevalence and clinical correlates of apathy in Parkinson's disease: A community-based study.  Parkinsonism Relat Disord. 2008; 
    Google Scholar
  • 20 Dujardin K, Sockeel P, Devos D. et al . Characteristics of apathy in Parkinson's disease.  Mov Disord. 2007;  22 778-784
    Google Scholar
  • 21 Aarsland D, Larsen J P, Lim N G. et al . Range of neuropsychiatric disturbances in patients with Parkinson's disease.  Journal of neurology, neurosurgery, and psychiatry. 1999;  67 492-496
    Google Scholar
  • 22 Starkstein S E, Mayberg H S, Preziosi T J. et al . Reliability, validity, and clinical correlates of apathy in Parkinson's disease.  The Journal of neuropsychiatry and clinical neurosciences. 1992;  4 134-139
    Google Scholar
  • 23 Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?.  Journal of neurology, neurosurgery, and psychiatry. 2000;  69 308-312
    Google Scholar
  • 24 Kuopio A M, Marttila R J, Helenius H. et al . The quality of life in Parkinson's disease.  Mov Disord. 2000;  15 216-223
    Google Scholar
  • 25 Kuhn W, Heye N, Muller T. et al . The motor performance test series in Parkinson's disease is influenced by depression.  J Neural Transm. 1996;  103 349-354
    Google Scholar
  • 26 Brown R, Jahanshahi M. Depression in Parkinson's disease: a psychosocial viewpoint.  Advances in neurology. 1995;  65 61-84
    Google Scholar
  • 27 Cummings J L, Masterman D L. Depression in patients with Parkinson's disease.  International journal of geriatric psychiatry. 1999;  14 711-718
    Google Scholar
  • 28 Santamaria J, Tolosa E, Valles A. Parkinson's disease with depression: a possible subgroup of idiopathic parkinsonism.  Neurology. 1986;  36 1130-1133
    Google Scholar
  • 29 Shiba M, Bower J H, Maraganore D M. et al . Anxiety disorders and depressive disorders preceding Parkinson's disease: a case-control study.  Mov Disord. 2000;  15 669-677
    Google Scholar
  • 30 Brown R G, MacCarthy B, Gotham A M. et al . Depression and disability in Parkinson's disease: a follow-up of 132 cases.  Psychological medicine. 1988;  18 49-55
    Google Scholar
  • 31 Lemke M R, Fuchs G, Gemende I. et al . Depression and Parkinson's disease.  J Neurol. 2004;  251 Suppl 6 VI/24-27
    Google Scholar
  • 32 Marder K, Tang M X, Cote L. et al . The frequency and associated risk factors for dementia in patients with Parkinson's disease.  Archives of neurology. 1995;  52 695-701
    Google Scholar
  • 33 Starkstein S E, Petracca G, Chemerinski E. et al . Depression in classic versus akinetic-rigid Parkinson's disease.  Mov Disord. 1998;  13 29-33
    Google Scholar
  • 34 Giladi N, Treves T A, Paleacu D. et al . Risk factors for dementia, depression and psychosis in long-standing Parkinson's disease.  J Neural Transm. 2000;  107 59-71
    Google Scholar
  • 35 Derix M MA, Gilhuis H J, Hoogendijk W J. Depressive syndrome in Parkinson' disease: diagnostic pitfalls. In: Wolters EC, Scheltens P (eds). Mental dysfunction in Parkinson's disease. Amsterdam: Krijek University Press 1993: 335-353
    Google Scholar
  • 36 Cummings J L. Depression and Parkinson's disease: a review.  The American journal of psychiatry. 1992;  149 443-454
    Google Scholar
  • 37 Poewe W, Luginger E. Depression in Parkinson's disease: impediments to recognition and treatment options.  Neurology. 1999;  52 S2-6
    Google Scholar
  • 38 Judd L L, Rapaport M H, Paulus M P. et al . Subsyndromal symptomatic depression: a new mood disorder?.  The Journal of clinical psychiatry. 1994;  55 Suppl 18-28
    Google Scholar
  • 39 Maricle R A, Nutt J G, Carter J H. Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: preliminary findings.  Mov Disord. 1995;  10 329-332
    Google Scholar
  • 40 Richard I H, Justus A W, Kurlan R. Relationship between mood and motor fluctuations in Parkinson's disease.  The Journal of neuropsychiatry and clinical neurosciences. 2001;  13 35-41
    Google Scholar
  • 41 Marsh L, McDonald W M, Cummings J. et al . Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group.  Mov Disord. 2006;  21 148-158
    Google Scholar
  • 42 Dujardin K, Sockeel P, Delliaux M. et al . The Lille Apathy Rating Scale: validation of a caregiver-based version.  Mov Disord. 2008;  23 845-849
    Google Scholar
  • 43 Lauterbach E C, Freeman A, Vogel R L. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease.  The Journal of neuropsychiatry and clinical neurosciences. 2004;  16 29-36
    Google Scholar
  • 44 Nilsson F M, Kessing L V, Bolwig T G. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study.  Acta psychiatrica Scandinavica. 2001;  104 380-386
    Google Scholar
  • 45 Schuurman A G, Akker M van den, Ensinck K T. et al . Increased risk of Parkinson's disease after depression: a retrospective cohort study.  Neurology. 2002;  58 1501-1504
    Google Scholar
  • 46 Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.  Schweiz Arch Neurol Psychiatr. 1995;  146 5-16
    Google Scholar
  • 47 Angst J, Preisig M. Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985.  Schweiz Arch Neurol Psychiatr. 1995;  146 17-23
    Google Scholar
  • 48 Remy P, Doder M, Lees A. et al . Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.  Brain. 2005;  128 1314-1322
    Google Scholar
  • 49 Mann J J. Role of the serotonergic system in the pathogenesis of major depression and suicidal behavior.  Neuropsychopharmacology. 1999;  21 99S-105S
    Google Scholar
  • 50 Sargent P A, Kjaer K H, Bench C J. et al . Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100 635: effects of depression and antidepressant treatment.  Archives of general psychiatry. 2000;  57 174-180
    Google Scholar
  • 51 Meyer J H, Kapur S, Eisfeld B. et al . The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.  The American journal of psychiatry. 2001;  158 78-85
    Google Scholar
  • 52 Meyer J H, Kapur S, Houle S. et al . Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study.  The American journal of psychiatry. 1999;  156 1029-1034
    Google Scholar
  • 53 Messa C, Colombo C, Moresco R M. et al . 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study.  Psychopharmacology. 2003;  167 72-78
    Google Scholar
  • 54 Zanardi R, Artigas F, Moresco R. et al . Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study.  Journal of clinical psychopharmacology. 2001;  21 53-58
    Google Scholar
  • 55 Meyer J H. Imaging the serotonin transporter during major depressive disorder and antidepressant treatment.  J Psychiatry Neurosci. 2007;  32 86-102
    Google Scholar
  • 56 Meyer J H, Houle S, Sagrati S. et al . Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes.  Archives of general psychiatry. 2004;  61 1271-1279
    Google Scholar
  • 57 Mann J J, Huang Y Y, Underwood M D. et al . A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide.  Archives of general psychiatry. 2000;  57 729-738
    Google Scholar
  • 58 Mann J J, Malone K M. Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients.  Biological psychiatry. 1997;  41 162-171
    Google Scholar
  • 59 Brooks D J, Piccini P. Imaging in Parkinson's disease: the role of monoamines in behavior.  Biological psychiatry. 2006;  59 908-918
    Google Scholar
  • 60 Kim S E, Choi J Y, Choe Y S. et al . Serotonin transporters in the midbrain of Parkinson's disease patients: a study with 123I-beta-CIT SPECT.  J Nucl Med. 2003;  44 870-876
    Google Scholar
  • 61 O'Suilleabhain P E, Sung V, Hernandez C. et al . Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations.  Archives of neurology. 2004;  61 865-868
    Google Scholar
  • 62 Hoogendijk W J, Sommer I E, Tissingh G. et al . Depression in Parkinson's disease. The impact of symptom overlap on prevalence.  Psychosomatics. 1998;  39 416-421
    Google Scholar
  • 63 Koenig H G, George L K, Peterson B L. et al . Depression in medically ill hospitalized older adults: prevalence, characteristics, and course of symptoms according to six diagnostic schemes.  The American journal of psychiatry. 1997;  154 1376-1383
    Google Scholar
  • 64 McDowell I, Newel C. Measuring health. A guide to rating scales and questionaires. 2nd ed. Oxford: Oxford University Press 1996
    Google Scholar
  • 65 Snaith R P, Zigmond A S. The hospital anxiety and depression scale.  British medical journal Clinical research ed. 1986;  292 344
    Google Scholar
  • 66 Mondolo F, Jahanshahi M, Grana A. et al . The validity of the hospital anxiety and depression scale and the geriatric depression scale in Parkinson's disease.  Behavioural neurology. 2006;  17 109-115
    Google Scholar
  • 67 Hamilton M. Development of a rating scale for primary depressive illness.  The British journal of social and clinical psychology. 1967;  6 278-296
    Google Scholar
  • 68 Dissanayaka N N, Sellbach A, Matheson S. et al . Validity of Hamilton Depression Inventory in Parkinson's disease.  Mov Disord. 2007;  22 399-403
    Google Scholar
  • 69 Montgomery S A, Asberg M. A new depression scale designed to be sensitive to change.  Br J Psychiatry. 1979;  134 382-389
    Google Scholar
  • 70 Fahn S, Elton R L, Committee U D. The Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB (eds). Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information 1987: 153-163, 293 – 304
    Google Scholar
  • 71 Schrag A, Barone P, Brown R G. et al . Depression rating scales in Parkinson's disease: critique and recommendations.  Mov Disord. 2007;  22 1077-1092
    Google Scholar
  • 72 Kuhner C, Burger C, Keller F. et al . Reliability and validity of the Revised Beck Depression Inventory (BDI-II). Results from German samples.  Der Nervenarzt. 2007;  78 651-656
    Google Scholar
  • 73 Sockeel P, Dujardin K, Devos D. et al . The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.  Journal of neurology, neurosurgery, and psychiatry. 2006;  77 579-584
    Google Scholar
  • 74 Robert P H, Clairet S, Benoit M. et al . The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment.  International journal of geriatric psychiatry. 2002;  17 1099-1105
    Google Scholar
  • 75 Marin R S, Biedrzycki R C, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale.  Psychiatry research. 1991;  38 143-162
    Google Scholar
  • 76 Pedersen K F, Larsen J P, Aarsland D. Validation of the Unified Parkinson's Disease Rating Scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease.  Parkinsonism Relat Disord. 2008;  14 183-186
    Google Scholar
  • 77 Primack B A. The WHO-5 Wellbeing Index performed the best in screening for depression in primary care.  ACP journal club. 2003;  139 48
    Google Scholar
  • 78 Mergl R, Seidscheck I, Allgaier A K. et al . Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition.  Depression and anxiety. 2007;  24 185-195
    Google Scholar
  • 79 Brand S, Dodel R, Hautzinger M. et al . [Depression in Parkinson's disease. Assessment and treatment].  Der Nervenarzt. 2007;  78 715-727; quiz 728
    Google Scholar

Prof. Dr. med. Alexander Storch

Klinik und Poliklinik für Neurologie, Technische Universität

Fetscherstraße 74

01307 Dresden

Email: alexander.storch@neuro.med.tu-dresden.de

      >